Title: Georg Lipps - Innovator in Pharmaceutical Formulations
Introduction
Georg Lipps is an inventor based in Riehen, Switzerland. He is currently associated with NBE-Therapeutics AG, where he contributes to the development of innovative pharmaceutical formulations. Despite having no granted patents, his work in the field of drug delivery systems is noteworthy.
Latest Patent Applications
Georg Lipps has been involved in several significant patent applications. One of his latest applications is titled "Controlled Drug Release Formulation." This application describes a pharmaceutical formulation dosage form with a core encapsulated by at least one shell, which includes at least one active pharmaceutical ingredient. The core is formed by a matrix based on xyloglucan, containing the active pharmaceutical ingredient, while the shell is a pH-responsive coating.
Another notable application is "Sortase F and Its Use in Methods for Conjugation." This invention relates to a method for producing a conjugate of two substrates. The method involves enzymatically conjugating the two substrates using a sortase F enzyme. The reaction occurs in an aqueous medium with a specific salt concentration, resulting in a conjugated product of the two substrates.
Conclusion
Georg Lipps is making strides in the pharmaceutical industry through his innovative approaches to drug formulation and conjugation methods. His contributions, although not yet reflected in granted patents, showcase his potential impact on the field.